New technology that opens the door to personalised therapies designed to treat cancer
IK4-TEKNIKER is conducting research into the electrochemical detection of biomarkers linked to cancer and inflammatory diseases in human serum. The technology, which is in the automation phase, will allow the cells that express these markers to be immobilised, and the over-expression of markers in the cell membrane itself to be detected; it is an achievement that opens up the door to the future development of personalised therapies.
Congresses.